Concepedia

Abdul‐rizaq Hamoud

AH

Statistics

Publications

5

Citations

166

H-Index

5

Active since

1989

Affiliations

University of Toledo(Current)

Creighton University

Neurosciences Institute

Abdul‐rizaq Hamoud is an author at University of Toledo specializing in viral hepatitis, hepatology, and hepatotoxicity management.

ORCID

Publications per year

1989–2024

5

Publications

5

Bilirubin remodels murine white adipose tissue by reshaping mitochondrial activity and the coregulator profile of peroxisome proliferator–activated receptor α

Darren M. Gordon, Kari L. Neifer, Abdul‐rizaq Hamoud et al. · Journal of Biological Chemistry · 2020 · 97 citations · Full text

, , +17

[Hepatitis caused by clometacin (Dupéran). Retrospective study of 30 cases. A model of autoimmune drug-induced hepatitis?].

E A Pariente, Abdul‐rizaq Hamoud, D Goldfain et al. · PubMed · 1989 · 36 citations

, , +11

Altered purinergic receptor expression in the frontal cortex in schizophrenia

Rawan Alnafisah, Anna Lundh, Sophie M. Asah et al. · Schizophrenia · 2022 · 12 citations · Full text

, , +14

In silico transcriptome screens identify epidermal growth factor receptor inhibitors as therapeutics for noise-induced hearing loss

Sarath Vijayakumar, Joseph DiGuiseppi, Parinaz J. Dabestani et al. · Science Advances · 2024 · 11 citations · Full text

, , +15

Piplartine attenuates aminoglycoside-induced TRPV1 activity and protects from hearing loss in mice

Marisa Zallocchi, Sarath Vijayakumar, Jonathan P. Fleegel et al. · Science Translational Medicine · 2024 · 10 citations · Full text

, , +16

1–5 of 5